JERUSALEM--(BUSINESS WIRE)--March 6, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Topiramate Tablets, 50 mg. Teva previously received tentative approval for the 25 mg, 100 mg and 200 mg strengths of this drug product. Final approval is anticipated upon expiry of patent protection in September 2008.
